Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Short Interest Update

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) was the recipient of a large drop in short interest in the month of August. As of August 14th, there was short interest totaling 118,989 shares, a drop of 47.0% from the July 30th total of 224,453 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 157,426 shares, the short-interest ratio is currently 0.8 days.

Analyst Upgrades and Downgrades

Separately, Kepler Capital Markets upgraded Coloplast A/S to a “strong-buy” rating in a report on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold”.

Coloplast A/S Price Performance

Shares of CLPBY traded up $0.01 during trading hours on Friday, hitting $7.17. 72,894 shares of the company were exchanged, compared to its average volume of 113,325. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.75 and a quick ratio of 1.09. The company has a market capitalization of $16.16 billion, a PE ratio of 37.74, a PEG ratio of 2.70 and a beta of 0.13. The firm has a fifty day simple moving average of $6.44 and a 200-day simple moving average of $6.61. Coloplast A/S has a one year low of $5.64 and a one year high of $10.03.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings results on Tuesday, August 18th. The company reported $0.10 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.10. Coloplast A/S had a return on equity of 38.81% and a net margin of 9.68%.The business had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.11 billion. As a group, sell-side analysts predict that Coloplast A/S will post 0.4 earnings per share for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.